Articles in the Current Issue
|
 |
The Full Burden of Cancer Michael J. Hassett (p. 793) |
|
Treatment Beyond Progression: Is It Moving from Belief to Evidence? Rinat Yerushalmi, Karen Gelmon (p. 796) |
|
Efficacy of Trastuzumab in Routine Clinical Practice and After Progression for Metastatic Breast Cancer Patients: The Observational Hermine Study Jean-Marc Extra, Eric C. Antoine, Anne Vincent-Salomon, Thierry Delozier, Pierre Kerbrat, Anne Bethune-Volters, Jean-Paul Guastalla, Marc Spielmann, Louis Mauriac, Jean-Louis Misset, Daniel Serin, Mario Campone, Christophe Hebert, Céline Remblier, Loïc Bergougnoux, Frank Campana, Moïse Namer (p. 799) |
|
A Phase II Study of Pazopanib in Patients with Recurrent or Metastatic Invasive Breast Carcinoma: A Trial of the Princess Margaret Hospital Phase II Consortium Sara K. Taylor, Stephen Chia, Susan Dent, Mark Clemons, Mark Agulnik, Pamela Grenci, Lisa Wang, Amit M. Oza, Percy Ivy, Kathleen I. Pritchard, Natasha B. Leighl (p. 810) |
|
Bevacizumab Filis Kazazi-Hyseni, Jos H. Beijnen, Jan H. M. Schellens (p. 819) |
|
When Treating Cancer, Please Don't Forget Hepatitis B Lindsay Y. King, Raymond T. Chung (p. 826) |
|
A Serious Complication of Selected Internal Radiation Therapy: Case Report and Literature Review Katrin M. Sjoquist, David Goldstein, Lourens Bester (p. 830) |
|
Mucinous Adenocarcinomas with Intra-Abdominal Dissemination: A Review of Current Therapy Thomas Winder, Heinz-Josef Lenz (p. 836) |
|
A Safety and Survival Analysis of Neoadjuvant Bevacizumab with Standard Chemoradiation in a Phase I/II Study Compared with Standard Chemoradiation in Locally Advanced Rectal Cancer Christopher G. Willett, Dan G. Duda, Marek Ancukiewicz, Mira Shah, Brian G. Czito, Rex Bentley, Martin Poleski, Hiroshi Fujita, Gregory Y. Lauwers, Madeline Carroll, Douglas Tyler, Christopher Mantyh, Paul Shellito, Daniel C. Chung, Jeffrey W. Clark, Rakesh K. Jain (p. 845) |
|
Treatment for Advanced and Recurrent Endometrial Carcinoma: Combined Modalities J. Alejandro Rauh-Hain, Marcela G. del Carmen (p. 852) |
|
Adjuvant Therapy in Non-Small Cell Lung Cancer: Current and Future Directions Randeep Sangha, Julie Price, Charles A. Butts (p. 862) |
|
Conditional Survival Among Cancer Patients in the United States Ray M. Merrill, Bradley D. Hunter (p. 873) |
|
Economic Burden for Informal Caregivers of Lung and Colorectal Cancer Patients Courtney Harold Van Houtven, Scott D. Ramsey, Mark C. Hornbrook, Audie A. Atienza, Michelle van Ryn (p. 883) |
|
Efficacy and Safety of Oral Lactoferrin Supplementation in Combination with rHuEPO-β for the Treatment of Anemia in Advanced Cancer Patients Undergoing Chemotherapy: Open-Label, Randomized Controlled Study Antonio Macciò, Clelia Madeddu, Giulia Gramignano, Carlo Mulas, Eleonora Sanna, Giovanni Mantovani (p. 894) |
|
Predictors of Chemotherapy Patients' Intentions to Engage in Medical Error Prevention David L.B. Schwappach, Martin Wernli (p. 903) |
|
Taste Alterations in Cancer Patients Receiving Chemotherapy: A Neglected Side Effect? August Zabernigg, Eva-Maria Gamper, Johannes M. Giesinger, Gerhard Rumpold, Georg Kemmler, Klaus Gattringer, Barbara Sperner-Unterweger, Bernhard Holzner (p. 913) |
|
|
|
